Medifast (MED) Enterprise Value (2010 - 2026)

Medifast has reported Enterprise Value for 17 years, with the latest figure at -$168.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 2.64% year-over-year to -$168.9 million; the trailing twelve-month figure through Mar 2026 stood at -$168.9 million (down 2.64% YoY), and the FY2025 full-year result was -$167.3 million, down 3.04% from the prior year.
• Enterprise Value for Q1 2026 stood at -$168.9 million, down from -$167.3 million in the prior quarter.
• The five-year high for Enterprise Value was -$61.1 million in Q2 2022, with the low at -$173.5 million in Q3 2025.
• Historically, Enterprise Value has averaged -$141.7 million across 5 years, with a median of -$157.8 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 69.07% — and 2023, when it sank 141.37%.
• Medifast's Enterprise Value stood at -$87.7 million in 2022, then sank by 71.1% to -$150.0 million in 2023, then retreated by 8.2% to -$162.3 million in 2024, then retreated by 3.04% to -$167.3 million in 2025, then declined by 1.0% to -$168.9 million in 2026.
• The last three Enterprise Value figures came in at -$168.9 million (Q1 2026), -$167.3 million (Q4 2025), and -$173.5 million (Q3 2025), per Business Quant data.